Company news
Rain Enhancement Technologies Holdco, Inc. (NASDAQ:RAIN) news
Every Rain Enhancement Technologies Holdco, Inc. press release and news update in one place — announcements, filings coverage, and company updates for invest...
View Rain Enhancement Technologies Holdco, Inc. stock analysis →
Press releases & updates
Rainier Acquisition Corporation Announces Separation of Its Class A Ordinary Shares and Warrants on Nasdaq, Commencing September 14, 2026
September 11, 2026
Rain Enhancement Technologies to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 9, 2026
Rainier Acquisition Corporation Announces Full Exercise of Over-Allotment Option, Bringing Total IPO Gross Proceeds to $86,250,000
September 2, 2026
Rain Enhancement Technologies Announces Agreement with California Highway Patrol to Test Fog Mitigation Technology
September 1, 2026
Rainier Acquisition Corporation Announces Closing of $75,000,000 Initial Public Offering
August 28, 2026
Rainier Acquisition Corporation Announces Pricing of $75,000,000 Initial Public Offering
August 26, 2026
Rain Enhancement Technologies Recognized With 2026 "AgTech Climate Innovation of the Year" by AgTech Breakthrough
August 21, 2026
Rain Enhancement Technologies Reports Business Progress, Hosts Webcast Today
August 12, 2026
Rain Enhancement Technologies Signs Exclusive Agreement with UASIT to Deploy WETA Platform in Türkiye
August 6, 2026
Rain Enhancement Technologies to Discuss Business Progress on Wednesday, August 12, 2026
August 5, 2026
Rain Enhancement Technologies to Present Four Precipitation Enhancement Studies at AMS Madison Summit
July 30, 2026
Rain Enhancement Technologies Announces Support for Colorado Weather Enhancement Paid Pilot Application, Target Install by October 2026
July 21, 2026
Rain Enhancement Technologies Reports WETA Delivers New Water at $10 Per Acre-Foot, a Fraction of the Cost of Conventional Supply Alterna...
June 9, 2026
Rain Enhancement Technologies Introduces Industry-First Guaranteed 10% Precipitation Enhancement
April 27, 2026
Rain City Resources Announces Revocation of Management Cease Trade Order
April 3, 2026
Rain Enhancement Technologies Reports Consistent Snowpack Enhancement Across Three-Month Winter Operations in Utah
March 31, 2026
Rain City Resources Provides Update on Management Cease Trade Order
March 26, 2026
Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations
February 12, 2026
Rain Enhancement Technologies Reports More Than 20% Snowpack Enhancement in Utah During January Operations
February 12, 2026
Rain Enhancement Technologies Expands Research into Air Quality and Smog Mitigation
February 5, 2026
Rain Enhancement Technologies Appoints David Sylvester, CFO of Steelcase, to Board of Directors
December 18, 2025
Rain Enhancement Technologies Reports Early Positive Indications From First Two U.S. Installations
December 16, 2025
Rain Enhancement Technologies Secures Second U.S. Installation with Utah Permit Approval, Advances Snow Enhancement Capabilities
November 18, 2025
Rain Enhancement Technologies Launches First U.S. Installation with Colorado Permit Approval
November 11, 2025
Rain Enhancement Technologies Holdco, Inc. Regains Compliance with Nasdaq Listing Requirements
November 7, 2025
Rain Enhancement Technologies Exhibits at Premier WMO Scientific Conference, Showcases Ionization Research Advancements
October 30, 2025
Rain Enhancement Technologies Reports Promising Results from Australia Fog Mitigation Pilot, Plans Expanded US Testing
October 28, 2025
Rain Enhancement Technologies Strengthens Strategic Leadership with Quantum Physics Pioneer and Corporate Governance Expert
October 15, 2025
Rain Enhancement Technologies Assembles World-Class Technical Advisory Board to Advance Weather Enhancement Innovation
September 18, 2025
RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC. RECEIVES AND APPEALS NASDAQ DELISTING NOTICE
August 22, 2025
Rain Enhancement Technologies Announces Fog Mitigation Pilot in Australia
August 20, 2025
Rain Enhancement Technologies Strengthens Board of Directors with Appointment of Industry Veterans Bob Reardon and Marc Peperzak
August 12, 2025
Rain Enhancement Technologies Announces Appointment of Scott Morris as Senior Technical Advisor
August 7, 2025
Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer
February 3, 2025
Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
August 10, 2023
Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023
July 26, 2023
Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma
May 22, 2023
Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
April 5, 2023
Rain Oncology to Report Fourth Quarter and Full Year 2022 Financial Results and Highlights of Recent Progress on March 9, 2023
February 23, 2023
Rain Therapeutics Inc. Announces Name Change to Rain Oncology Inc.
December 29, 2022
Rain Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
November 10, 2022
Rain Therapeutics Provides Interim Analysis of Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)
November 4, 2022
Rain Therapeutics Announces $50 Million Registered Offering of Common Stock
November 4, 2022
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium
October 26, 2022
Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma
August 4, 2022
Rain Therapeutics Announces a Poster Presentation and Trials In Progress at the American Association for Cancer Research (AACR) Annual Me...
April 1, 2022
Rain Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Progress
March 3, 2022
Rain Therapeutics Continues to Strengthen its Leadership Team with Key Appointments
February 8, 2022
Rain Therapeutics Doses First Patient in Phase 2 Basket Trial of Milademetan for MDM2-Amplified Advanced Solid Tumors (MANTRA-2)
November 19, 2021
Rain Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Progress
November 10, 2021